NCT06906783 Transtibial Pull Out Method Versus Suture Anchor Method for Meniscus Extrusion
| NCT ID | NCT06906783 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ataturk University |
| Condition | Meniscal Extrusion |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2024-10-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The concept of meniscal extrusion has recently been recognized as an important pathological condition associated with meniscal dysfunction. Meniscal extrusion is the medial or lateral displacement of the meniscus beyond the edges of the tibial plateau. Some meniscal extrusions are physiologic, but large degrees of extrusion are thought to be pathologic. Meniscal extrusion can vary in extent from minimal physiological extrusion to extrusions exceeding 10 mm. The generally accepted threshold value is considered to be 3 mm. To date, the gold standard for measuring meniscal extrusion is T2-weighted MRI. MRI is valuable not only due to its ability to define other meniscal or knee pathologies but also because it provides good sensitivity and specificity. Surgical treatment of meniscal extrusion is preferred in young, active, symptomatic patients and individuals with acute injuries. The treatment approach may vary depending on the underlying cause. One of these methods is centralization surgery, which aims to achieve the anatomical reduction of the extruded meniscus. The aim of this study is to compare the functional outcomes of transtibial pull-out and suture anchor techniques used in centralization surgery and to contribute to standardization.
Eligibility Criteria
Inclusion Criteria: * Presence of meniscal extrusion greater than 3 mm on MRI scans * Symptomatic complaints in the knee with extrusion Exclusion Criteria: * Malalignment greater than 5 degrees * Presence of Kellgren-Lawrence grade 3-4 osteoarthritis
Contact & Investigator
Ahmet E Paksoy, Assoc.Prof.
STUDY DIRECTOR
Ataturk University
Frequently Asked Questions
Who can join the NCT06906783 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Meniscal Extrusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06906783 currently recruiting?
Yes, NCT06906783 is actively recruiting participants. Contact the research team at drcelik@outlook.com for enrollment information.
Where is the NCT06906783 trial being conducted?
This trial is being conducted at Erzurum, Turkey (Türkiye).
Who is sponsoring the NCT06906783 clinical trial?
NCT06906783 is sponsored by Ataturk University. The principal investigator is Ahmet E Paksoy, Assoc.Prof. at Ataturk University. The trial plans to enroll 46 participants.